Cargando…

IGF2BP1, a New Target to Overcome Drug Resistance in Melanoma?

Detalles Bibliográficos
Autores principales:	Xi, Yufeng, Wang, Yujia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354603/ https://www.ncbi.nlm.nih.gov/pubmed/35935853 http://dx.doi.org/10.3389/fphar.2022.947363

Ejemplares similares

LINC01001 Promotes Progression of Crizotinib-Resistant NSCLC by Modulating IGF2BP2/MYC Axis
por: Zhang, Meiling, et al.
Publicado: (2021)

Combating and overcoming drug resistance in cancer
por: Price, Douglas K.
Publicado: (2014)

New Approaches to Overcome Transport Related Drug Resistance in Trypanosomatid Parasites
por: Garcia-Salcedo, Jose A., et al.
Publicado: (2016)

Targeting Ubiquitin-Specific Protease 7 (USP7) in Cancer: A New Insight to Overcome Drug Resistance
por: Lu, Jiabin, et al.
Publicado: (2021)

Targeted chemotherapy overcomes drug resistance in melanoma
por: Yue, Jingyin, et al.
Publicado: (2020)

Targeting IGF2BP3 in Cancer
por: Liu, Xin, et al.
Publicado: (2023)

Drugging the Epigenome: Overcoming Resistance to Targeted and Immunotherapies in Melanoma
por: Hanly, Ailish, et al.
Publicado: (2021)

Modulation of redox homeostasis: A strategy to overcome cancer drug resistance
por: Li, Yang, et al.
Publicado: (2023)

Drug-resistant HER2-positive breast cancer: Molecular mechanisms and overcoming strategies
por: Wu, Xiaofan, et al.
Publicado: (2022)

Mechanistic Insights Into Co-Administration of Allosteric and Orthosteric Drugs to Overcome Drug-Resistance in T315I BCR-ABL1
por: Zhang, Hao, et al.
Publicado: (2022)

Norcantharidin overcomes vemurafenib resistance in melanoma by inhibiting pentose phosphate pathway and lipogenesis via downregulating the mTOR pathway
por: Wang, Lei, et al.
Publicado: (2022)

Targeting Tumor Associated Macrophages to Overcome Conventional Treatment Resistance in Glioblastoma
por: Grégoire, Hélène, et al.
Publicado: (2020)

Extracellular vesicle-dependent effect of RNA-binding protein IGF2BP1 on melanoma metastasis
por: Ghoshal, Archita, et al.
Publicado: (2019)

Overcoming Obstacles to Drug Repositioning in Japan
por: Nishimura, Yuhei, et al.
Publicado: (2017)

Is redox signaling a feasible target for overcoming multidrug resistance in cancer chemotherapy?
por: Polimeni, Manuela, et al.
Publicado: (2014)

The IGF2/IGF1R/Nanog Signaling Pathway Regulates the Proliferation of Acute Myeloid Leukemia Stem Cells
por: Xu, Dan-dan, et al.
Publicado: (2018)

Targeting immune cell types of tumor microenvironment to overcome resistance to PD-1/PD-L1 blockade in lung cancer
por: Wang, Man, et al.
Publicado: (2023)

Investigation of Igf-1, Igf-Bp3 and Igf-Bp5 levels in umbilical cord blood of infants with developmental dysplasia of the hip
por: DEMİREL, Esra, et al.
Publicado: (2023)

Understanding the Emerging Link Between Circadian Rhythm, Nrf2 Pathway, and Breast Cancer to Overcome Drug Resistance
por: Bevinakoppamath, Supriya, et al.
Publicado: (2022)

Iron (II) Polypyridyl Complexes as Antiglioblastoma Agents to Overcome the Blood-Brain Barrier and Inhibit Cell Proliferation by Regulating p53 and 4E-BP1 Pathways
por: Zhu, Huili, et al.
Publicado: (2019)

AhR Antagonist Promotes Differentiation of Papillary Thyroid Cancer via Regulating circSH2B3/miR-4640-5P/IGF2BP2 Axis
por: Sa, Ri, et al.
Publicado: (2021)

Nanoparticles overcome adaptive immune resistance and enhance immunotherapy via targeting tumor microenvironment in lung cancer
por: Zhang, Xin, et al.
Publicado: (2023)

Expression of the cancer testis antigen IGF2BP3 in colorectal cancers; IGF2BP3 holds promise as a specific immunotherapy target
por: Shantha Kumara, HMC, et al.
Publicado: (2015)

Role of the IGF-1 Axis in Overcoming Resistance in Breast Cancer
por: Ianza, Anna, et al.
Publicado: (2021)

lncRNA AGAP2-AS1 Facilitates Tumorigenesis and Ferroptosis Resistance through SLC7A11 by IGF2BP2 Pathway in Melanoma
por: An, Lifeng, et al.
Publicado: (2022)

Commentary: Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor
por: Renna, Maurizio
Publicado: (2016)

EGF and IGF1 affect sunitinib activity in BP-NEN: new putative targets beyond VEGFR?
por: Bresciani, Giulia, et al.
Publicado: (2019)

Targeting PAR2 Overcomes Gefitinib Resistance in Non-Small-Cell Lung Cancer Cells Through Inhibition of EGFR Transactivation
por: Jiang, Yuhong, et al.
Publicado: (2021)

CD44(+) fibroblasts increases breast cancer cell survival and drug resistance via IGF2BP3‐CD44‐IGF2 signalling
por: Liu, Yonglei, et al.
Publicado: (2017)

Retracted: lncRNA AGAP2-AS1 Facilitates Tumorigenesis and Ferroptosis Resistance through SLC7A11 by IGF2BP2 Pathway in Melanoma
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

An isocorydine derivative (d-ICD) inhibits drug resistance by downregulating IGF2BP3 expression in hepatocellular carcinoma
por: Li, Meng, et al.
Publicado: (2015)

Antibiotic Combination Therapy: A Strategy to Overcome Bacterial Resistance to Aminoglycoside Antibiotics
por: Wang, Nuoyan, et al.
Publicado: (2022)

Therapeutic Suppression of FAK-AKT Signaling Overcomes Resistance to SHP2 Inhibition in Colorectal Carcinoma
por: Li, Ye, et al.
Publicado: (2021)

PRMT3-mediated arginine methylation of IGF2BP1 promotes oxaliplatin resistance in liver cancer
por: Shi, Yunxing, et al.
Publicado: (2023)

Scorpion Venom Heat–Resistant Synthesized Peptide Increases Stress Resistance and Extends the Lifespan of Caenorhabditis elegans via the Insulin/IGF-1-Like Signal Pathway
por: Wang, Ying-Zi, et al.
Publicado: (2022)

Reconstituted HDL: Drug Delivery Platform for Overcoming Biological Barriers to Cancer Therapy
por: Raut, Sangram, et al.
Publicado: (2018)

Overcoming barriers: a review on innovations in drug delivery to the middle and inner ear
por: Delaney, Derek S., et al.
Publicado: (2023)

Targeting Prohibitins to Inhibit Melanoma Growth and Overcome Resistance to Targeted Therapies
por: Najem, Ahmad, et al.
Publicado: (2023)

Jinmaitong, a Traditional Chinese Compound Prescription, Ameliorates the Streptozocin-Induced Diabetic Peripheral Neuropathy Rats by Increasing Sciatic Nerve IGF-1 and IGF-1R Expression
por: Song, Wei, et al.
Publicado: (2019)

New Hypoglycemic Drugs: Combination Drugs and Targets Discovery
por: Ni, Xiayun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_niv7ktti9h27p0er0cp3u7t7ep